HIV Medicine Association

04/25/2026

Is your state considering restrictions on HIV drugs? HIVMA’s policy brief offers key recommendations for state policymakers to reform prior authorization requirements, improve access to HIV medications and reduce health care costs.

Read the brief: https://bit.ly/4k3uO0n

04/23/2026

A fair price for Biktarvy is critical to ensure Medicare beneficiaries can access effective HIV treatment and support progress toward ending the HIV epidemic, stressed HIVMA board member Joseph Cherabie, MD, MSc, during yesterday's CMS Medicare Drug Pricing Program townhall.

Read Dr. Cherabie's comments: https://bit.ly/48LRL3O

04/22/2026

A new survey from The Well Project found that 72% of women and nonbinary people living with HIV in the U.S. reported experiencing stigmatizing language in healthcare settings, with many citing negative effects on their mental health, care engagement, and overall well-being.

Read the full report:

The Well Project, along with a group of expert advisors, sought to understand the extent and impact of stigmatizing language in healthcare settings - and what can be done.

04/21/2026

The president’s FY 2027 budget proposal calls for deep cuts to HIV prevention, care and research and includes a proposed elimination of HIV Prevention and Ryan White Program Part F, which would come at a high cost.

Learn more: https://bit.ly/3OPPDRQ

04/18/2026

Today marks National Transgender HIV Testing Day, a day to recognize the importance of routine HIV testing, status awareness, and continued focus on HIV prevention and treatment efforts among transgender and gender non-binary people.

Learn more: https://bit.ly/4tIhcLM

04/18/2026

JID is seeking proposals for papers focused on the use of long-acting antiretroviral therapies that explore new and innovative approaches to HIV care.

Learn more and submit your proposal by May 24: https://bit.ly/4ckQMZr

04/16/2026

New survey results from the Emergency HIV Clinical Task Force provide a stark look at the human impact of recent funding cuts and policy changes affecting HIV care.

Read the results: https://bit.ly/4tTU7WA

04/15/2026

Biktarvy is on the list of 15 drugs that will be subject to Medicare price negotiations taking effect in 2028. To help inform the price negotiation process, the Centers for Medicare and Medicaid Services is hosting a town hall next Wednesday, April 22 at 10:30am-12pm ET, featuring HIVMA Board member Joseph Cherabie, MD, MSc.

Learn more: https://go.cms.gov/48MGHmU

As part of the Medicare Drug Price Negotiation Program,

04/15/2026

DYK? Anyone having s*x can get an STI. This STI Awareness Week, know your STI care options and Get Yourself Tested! https://bit.ly/4dTyyh7

04/13/2026

Updated guidelines! The Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission has updated the Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States guidelines sections to address new data and publications where relevant.

Learn more:

04/10/2026

Today marks National Youth HIV & AIDS Awareness Day, a day to take action regarding the impact of HIV/AIDS on young people and to highlight the HIV prevention, treatment, and care campaigns of young people in the U.S.

Learn more: https://bit.ly/4snaCsP

04/09/2026

The Edward H. Kass Lecture is now available to the public! Watch HIVMA Past Chair Judith Feinberg, MD, FIDSA, reflect on early AIDS treatments and review key treatments and effective prophylaxis interventions from early clinical research in HIV: https://bit.ly/41t23lo